机构:[1]Department of Radiation Oncology, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Cheng Du, China四川省肿瘤医院[2]Department of Oncology, The Third People’s Hospital of Sichuan Province, Chengdu, China四川省人民医院[3]Chengdu Medical College, Chengdu, China[4]Department of Radiation Oncology, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China四川省肿瘤医院[5]Department of Radiation Oncology, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China四川省人民医院四川省肿瘤医院[6]Sichuan Cancer Hospital and Institution, Chengdu, China四川省肿瘤医院[7]Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China四川省人民医院四川省肿瘤医院[8]Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China四川省肿瘤医院[9]Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, China, Chengdu, TX, China四川省人民医院四川省肿瘤医院[10]Department of Radiation Oncology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Radiation Oncology Key Laboratory of Sichuan Province, Chengdu, China四川省肿瘤医院[11]University of Electronic Science and Technology of China, Chengdu, China[12]Sichuan Cancer Hospital and Institute, Chengdu, China四川省肿瘤医院[13]Department of Radiation Oncology, Sichuan Cancer Hospital& Institution, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Radiation oncology Key Laboratory of Sichuan Province, Chengdu, China四川省人民医院四川省肿瘤医院
第一作者机构:[1]Department of Radiation Oncology, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Cheng Du, China[2]Department of Oncology, The Third People’s Hospital of Sichuan Province, Chengdu, China
推荐引用方式(GB/T 7714):
Feng M,Yan L,Du X,et al.Early Efficacy Prediction of Nasopharyngeal Carcinoma Based on 3D-ADC Acquired During Radiotherapy: A Phase II Prospective Study.[J].INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS.2021,111(3):S21-S21.doi:10.1016/j.ijrobp.2021.07.077.
APA:
Feng M,Yan L,Du X,Wang H,Ren J...&Lang J.(2021).Early Efficacy Prediction of Nasopharyngeal Carcinoma Based on 3D-ADC Acquired During Radiotherapy: A Phase II Prospective Study..INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,111,(3)
MLA:
Feng M,et al."Early Efficacy Prediction of Nasopharyngeal Carcinoma Based on 3D-ADC Acquired During Radiotherapy: A Phase II Prospective Study.".INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 111..3(2021):S21-S21